Literature DB >> 19142714

Berberine reduces fibronectin and collagen accumulation in rat glomerular mesangial cells cultured under high glucose condition.

Weihua Liu1, Futian Tang, Yanhui Deng, Xuejuan Li, Tian Lan, Xiaoyan Zhang, Heqing Huang, Peiqing Liu.   

Abstract

Diabetic nephropathy, one of the microvascular complications of diabetes mellitus, is a leading cause of end-stage renal disease. Berberine is one of the main constituents of Coptidis Rhizoma and Cortex Phellodendri. In this study, we investigated the effects of berberine on fibronectin and collagen production, and explored the role of p38MAPK signaling pathway in rat glomerular mesangial cells cultured under high glucose condition. Six groups were divided according to the different experimental conditions: (1) Normal glucose group (NG); (2) Mannitol group (Mannitol); (3) High glucose group (HG); (4) SB203580 treatment group (HG + SB203580); (5) Berberine low dosage group (HG + BBR 30 microM); (6) Berberine high dosage group (HG + BBR 90 microM). Cell proliferation and collagen synthesis were measured by MTT and (3)H-proline incorporation assay, respectively. The phospho-p38MAPK, phospho-cAMP response element binding protein (CREB) and fibronectin were detected by western blot analysis. Fibronectin protein expression and collagen synthesis were significantly increased in HG-treated group compared with normal glucose group (P < 0.05). In SB203580 treatment group and two groups of berberine, protein expression of fibronectin and collagen synthesis were obviously decreased compared with HG-treated group (P < 0.05). Berberine significantly decreased protein expression of fibronectin compared with SB203580 treatment group (P < 0.05). Berberine at high dosage significantly decreased collagen synthesis compared with SB203580 treatment group (P < 0.05). Both SB203580 and berberine significantly decreased phospho-p38MAPK and phospho-CREB level compared with HG-treated group (P < 0.05). These results indicated that berberine might inhibit fibronectin and collagen synthesis partly via p38MAPK signal pathway in rat glomerular mesangial cells exposed to high glucose.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19142714     DOI: 10.1007/s11010-008-0024-y

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  35 in total

Review 1.  Diabetes: changing the fate of diabetics in the dialysis unit.

Authors:  Behrooz Broumand
Journal:  Blood Purif       Date:  2006-12-14       Impact factor: 2.614

2.  Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins.

Authors:  Weijia Kong; Jing Wei; Parveen Abidi; Meihong Lin; Satoru Inaba; Cong Li; Yanling Wang; Zizheng Wang; Shuyi Si; Huaining Pan; Shukui Wang; Jingdan Wu; Yue Wang; Zhuorong Li; Jingwen Liu; Jian-Dong Jiang
Journal:  Nat Med       Date:  2004-11-07       Impact factor: 53.440

Review 3.  Gene expression in diabetic nephropathy.

Authors:  Daniela Hohenadel; Fokko J van der Woude
Journal:  Curr Diab Rep       Date:  2004-12       Impact factor: 4.810

4.  Berberine, a natural cholesterol reducing product, exerts antitumor cytostatic/cytotoxic effects independently from the mevalonate pathway.

Authors:  Tadeusz Issat; Marek Jakóbisiak; Jakub Golab
Journal:  Oncol Rep       Date:  2006-12       Impact factor: 3.906

5.  Role of mitogen-activated protein kinase in the regulation of transforming growth factor-beta-induced fibronectin accumulation in cultured renal interstitial fibroblasts.

Authors:  Hitoe Suzuki; Keiko Uchida; Kosaku Nitta; Hiroshi Nihei
Journal:  Clin Exp Nephrol       Date:  2004-09       Impact factor: 2.801

6.  Inhibition of phosphorylation of p38 MAPK involved in the protection of nephropathy by emodin in diabetic rats.

Authors:  Jinping Wang; Heqing Huang; Peiqing Liu; Futian Tang; Jia Qin; Wenge Huang; Fengying Chen; Fenfen Guo; Weihua Liu; Bing Yang
Journal:  Eur J Pharmacol       Date:  2006-09-14       Impact factor: 4.432

7.  RSK-B, a novel ribosomal S6 kinase family member, is a CREB kinase under dominant control of p38alpha mitogen-activated protein kinase (p38alphaMAPK).

Authors:  B Pierrat; J S Correia; J L Mary; M Tomás-Zuber; W Lesslauer
Journal:  J Biol Chem       Date:  1998-11-06       Impact factor: 5.157

8.  Angiotensin II induction of fibronectin biosynthesis in cultured human mesangial cells: association with CREB transcription factor activation.

Authors:  N S Nahman; K L Rothe; M E Falkenhain; K M Frazer; L E Dacio; J D Madia; K L Leonhart; J C Kronenberger; D A Stauch
Journal:  J Lab Clin Med       Date:  1996-06

9.  Mitogen-activated protein kinase p38 mediates reduced nerve conduction velocity in experimental diabetic neuropathy: interactions with aldose reductase.

Authors:  Sally A Price; Sithiporn Agthong; Alicia B Middlemas; David R Tomlinson
Journal:  Diabetes       Date:  2004-07       Impact factor: 9.461

10.  Therapeutic effects of berberine in impaired glucose tolerance rats and its influence on insulin secretion.

Authors:  San-hua Leng; Fu-er Lu; Li-jun Xu
Journal:  Acta Pharmacol Sin       Date:  2004-04       Impact factor: 6.150

View more
  19 in total

1.  Curcumin diminishes the impacts of hyperglycemia on the activation of hepatic stellate cells by suppressing membrane translocation and gene expression of glucose transporter-2.

Authors:  Jianguo Lin; Anping Chen
Journal:  Mol Cell Endocrinol       Date:  2010-12-30       Impact factor: 4.102

2.  Intronic microRNA suppresses endothelial nitric oxide synthase expression and endothelial cell proliferation via inhibition of STAT3 signaling.

Authors:  Limei Yan; Hong Hao; Terry S Elton; Zhenguo Liu; Hesheng Ou
Journal:  Mol Cell Biochem       Date:  2011-05-25       Impact factor: 3.396

Review 3.  Expatiating the Pharmacological and Nanotechnological Aspects of the Alkaloidal Drug Berberine: Current and Future Trends.

Authors:  Tapan Behl; Sukhbir Singh; Neelam Sharma; Ishrat Zahoor; Ali Albarrati; Mohammed Albratty; Abdulkarim M Meraya; Asim Najmi; Simona Bungau
Journal:  Molecules       Date:  2022-06-09       Impact factor: 4.927

4.  Neuroprotective effect of berberine against learning and memory deficits in diffuse axonal injury.

Authors:  Hong-Cai Wang; Bo-Ding Wang; Mao-Song Chen; Hai Chen; Cheng-Feng Sun; Gang Shen; Jian-Min Zhang
Journal:  Exp Ther Med       Date:  2017-11-13       Impact factor: 2.447

5.  Berberine ameliorates renal injury by regulating G proteins-AC- cAMP signaling in diabetic rats with nephropathy.

Authors:  Li Qin Tang; Feng Ling Wang; Ling Na Zhu; Fei Lv; Sheng Liu; Shan Tang Zhang
Journal:  Mol Biol Rep       Date:  2012-12-25       Impact factor: 2.316

6.  Renoprotective effects of berberine and its possible molecular mechanisms in combination of high-fat diet and low-dose streptozotocin-induced diabetic rats.

Authors:  Feng Ling Wang; Li Qin Tang; Feng Yang; Ling Na Zhu; Ming Cai; Wei Wei
Journal:  Mol Biol Rep       Date:  2012-11-30       Impact factor: 2.316

7.  Berberine reduces fibronectin expression by suppressing the S1P-S1P2 receptor pathway in experimental diabetic nephropathy models.

Authors:  Kaipeng Huang; Weihua Liu; Tian Lan; Xi Xie; Jing Peng; Juan Huang; Shaogui Wang; Xiaoyan Shen; Peiqing Liu; Heqing Huang
Journal:  PLoS One       Date:  2012-08-24       Impact factor: 3.240

8.  Quinazolinobenzodiazepine Derivatives, Novobenzomalvins A-C: Fibronectin Expression Regulators from Aspergillus novofumigatus.

Authors:  Kazuki Ishikawa; Tomoo Hosoe; Takeshi Itabashi; Fumiaki Sato; Hiroshi Wachi; Hiromasa Nagase; Takashi Yaguchi; Ken-Ichi Kawai
Journal:  Sci Pharm       Date:  2011-10-03

9.  Geldanamycin derivative ameliorates high fat diet-induced renal failure in diabetes.

Authors:  Hong-Mei Zhang; Howard Dang; Amrita Kamat; Chih-Ko Yeh; Bin-Xian Zhang
Journal:  PLoS One       Date:  2012-03-06       Impact factor: 3.240

10.  Oryeongsan suppressed high glucose-induced mesangial fibrosis.

Authors:  Jung Joo Yoon; Yun Jung Lee; So Min Lee; Dae Gill Kang; Ho Sub Lee
Journal:  BMC Complement Altern Med       Date:  2015-02-22       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.